Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bionoid Pharma Inc (OP:BINP)

0.0617 UNCHANGED
Streaming Delayed Price Updated: 3:55 PM EDT, May 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0617
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0617
Today's Range 0.0617 - 0.0617
52wk Range 0.0220 - 0.4380
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
TechMediaBreaks – Bionoid Pharma Inc. (OTC PINK: BINP) Rebrands as AI Maverick Intel to Focus on AI-Driven Engagement
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Bionoid Pharma, Inc. Rebrands as AI Maverick Intel, Inc. to Reflect Strategic Shift Toward AI-Driven Innovation
Via ACCESS Newswire

Performance

YTD
-75.8%
-75.8%
1 Month
-20.9%
-20.9%
3 Month
-75.1%
-75.1%
6 Month
-69.1%
-69.1%
1 Year
-75.3%
-75.3%

More News

Read More
Bionoid Pharma Inc. Announces Completion of 2024 Financial Audit
Via ACCESS Newswire
Bionoid Pharma Inc. Engages Aloba, Awomolo & Partners as External Auditor for 2024 Financial Statements
Via ACCESS Newswire
Bionoid Pharma, Inc. Unveils Five-Year Strategic Roadmap
Via ACCESSWIRE
Bionoid Pharma, Inc. Acquires AI Maverick Intel
Via ACCESSWIRE
Bionoid Pharma Inc. Provides Update on Binding Letter of Intent to Acquire Global Alerts Corp.
Via ACCESSWIRE
Bionoid Pharma Signs Exclusive License Agreement with Global Alerts Corp.
Via ACCESSWIRE
Bionoid Pharma Announces Filing of OTCQB Application to Enhance Market Visibility and Liquidity
Via ACCESS Newswire
Bionoid Pharma, Inc. Announces Completion of 2022 and 2023 Financial Audits by PCAOB-Registered Firm
Via ACCESS Newswire
Bionoid Pharma, Inc. Provides Corporate Update and Outlines Growth Strategy for 2025
Via ACCESSWIRE
Bionoid Pharma, Inc. Reports Over $100,000 in Revenue Following Binding LOI With Your Supplement Supply Store Ltd.
Via ACCESSWIRE
Bionoid Pharma, Inc. Moves to Expand E-Commerce Presence With Binding Agreement to Acquire Platform From Vitawin Supplements Ltd.
Via ACCESSWIRE
Bionoid Pharma Extends Letter of Intent to Acquire Global Alerts Corp.
Via ACCESSWIRE
AI Maverick: The Next Evolution of Sales Automation Unveiled in Exclusive Podcast
Via ACCESSWIRE
The End of SDRs? AI Maverick Sales Automation, One Touchpoint at a Time
Via ACCESSWIRE
Bionoid Pharma, Inc. Launches Enhanced Supplements Ltd. to Drive Strategic E-Commerce Expansion
Via ACCESSWIRE
Bionoid Pharma, Inc. Signs Binding Letter of Intent to Acquire Main E-Commerce Platform of Your Supplement Supply Store Ltd.
Via ACCESSWIRE
Bionoid Pharma, Inc. Engages Olayinka Oyebola & Co. as PCAOB External Auditor for Annual Financial Audit
Via ACCESSWIRE
Bionoid Pharma Announces Agreement to Acquire AiMaverickIntel.com
Via ACCESSWIRE
Bionoid Pharma Announces Letter of Intent to Acquire Global Alerts Corp.
Via ACCESSWIRE

Frequently Asked Questions

Is Bionoid Pharma Inc publicly traded?
Yes, Bionoid Pharma Inc is publicly traded.
What exchange does Bionoid Pharma Inc trade on?
Bionoid Pharma Inc trades on the OTC Traded
What is the ticker symbol for Bionoid Pharma Inc?
The ticker symbol for Bionoid Pharma Inc is BINP on the OTC Traded
What is the current price of Bionoid Pharma Inc?
The current price of Bionoid Pharma Inc is 0.0617
When was Bionoid Pharma Inc last traded?
The last trade of Bionoid Pharma Inc was at 05/20/25 03:55 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.